The president of Bloomington-based Cook Medical Inc. says a new manufacturing plant on the near northside of Indianapolis is a win-win for everyone. The company, along with Goodwill of Central and Southern Indiana and the Central Indiana Community Foundation, this morning marked the opening of the facility, which will ultimately employ 100 area residents. ... Read More
Purdue University legend Dr. Philip Low admits he could buy a yacht and sail into the sunset, but that would ignore the call he feels to continue life-saving work: “If you can help a lot of people, I think it would be misdirected time not to do it,” he says. Men with advanced stage prostate […]... Read More
What started as a PhD project for a University of Notre Dame student has exploded into a “billion-dollar idea” that could transform imaging standards for breast cancer treatment. Called NearWave Imager, the handheld device will help doctors determine if a certain treatment is meeting its goal to shrink or kill a tumor. It’s an answer […]... Read More
Better care for kids today and finding new treatments for tomorrow is the vision of a $5 million gift from a Hoosier family. Called “transformative” and “monumental,” the money aims to make Riley Hospital for Children at IU Health a national model for Duchenne muscular dystrophy, a condition that has affected the Ackerman and Nicholoff […]... Read More
Powered by a $1.39 million National Institutes of Health (NIH) grant, a Butler University pharmacy professor is carrying out research that could uncover methods to detect an aggressive form of lymphoma at an earlier stage. Born and raised in Zimbabwe, Dr. Chioniso Patience Masamha’s unique heritage is likely opening doors for her students—many also from […]... Read More
West Lafayette-based Inotiv Inc. (Nasdaq: NOTV) has acquired Histion LLC, a provider of preclinical laboratory services. While financial terms of the acquisition were not disclosed, Inotiv says the acquisition is a strategic element to the expansion of its specialized pathology services.... Read More
Eli Lilly and Co. (NYSE: LLY) Chief Executive Officer Dave Ricks says while Indiana has built a low tax, business friendly environment that is attractive, there needs to be a focus on non-traditional factors if the state is going to be successful in the new economy. ... Read More
The new general manager of New Jersey-based Catalent Inc.'s (NYSE: CTLT) manufacturing facility in Bloomington says the company's continued expansion in Monroe County is unprecedented, but still "structured and planned growth." ... Read More
The chief executive officer of BioCrossroads says Catalent Pharma Solutions Inc. plans to invest $350 million to expand its Bloomington operations sends a message to other drugmakers. ... Read More
Indiana’s life sciences sector has just received another economic booster shot with a more than $350 million investment from New Jersey-based Catalent Inc... Read More
BioCrossroads has released its annual Indiana Life Sciences Capital report. The state's life sciences initiative says Hoosier life sciences companies accessed more than $15 billion in capital last year, a $6 billion increase over 2020.... Read More
Indianapolis-based Acacia Pharma Group will soon be under new ownership. Our partners at the Indianapolis Business Journal report the company is set to be acquired by Eagle Pharmaceuticals Inc. in New Jersey in a deal valued at nearly $104 million. ... Read More
The largest concussion and repetitive head impact study in history recently earned a 10-year extension to the tune of $42 million, and Indiana is continuing to help lead the charge. Recognizing that athletes and military cadets could answer some of the biggest questions surrounding head injuries, the NCAA, headquartered in Indianapolis, and Department of Defense […]... Read More
The state’s largest healthcare system has announced sweeping plans for “a renewed commitment to price affordability.” Indiana’s high hospital costs have become a hot topic after a recent study from the RAND Corp. found that Indiana ranked the highest for hospital costs among the 25 states that were analyzed. On the heels of announcing a […]... Read More
When her grandmother died of cancer, Dr. Thakshila Liyanage vowed to give doctors a better weapon to find cancer early. “If early diagnosis was possible, she should have had a much longer life,” says Liyanage. She devoted her studies, and now a business endeavor, to creating a tool that could accurately diagnose cancer at Stage […]... Read More
Combining the power of Purdue University engineers and veterinarians, a technology with “a very clear clinical need” is aiming to take a bite out of the electronic textile industry. Clothes that are embedded with electronic functions to monitor various health signals are becoming increasingly common, but this innovation gives the user the power of customization, […]... Read More
For the second time in less than six months, cancer-focused medical innovation based on work by Purdue University researcher Dr. Philip Low has received approval from the U.S. Food and Drug Administration. ... Read More
A Bloomington-based startup founded by two Indiana University chemistry professors has inked a deal with Massachusetts-based Waters Corp. (NYSE: WAT). Megadalton Solutions will license to Waters its charge detection mass spectrometry technology, which can be used in the development of cell and gene therapies.... Read More
West Lafayette-based On Target Laboratories Inc. has announced a clinical research and product development collaboration with Mauna Kea Technologies in Paris. On Target says the partnership aims to improve the identification and diagnosis of pulmonary cancers.... Read More
A subsidiary of Italy-based Stevanato Group (NYSE: STVN) has entered into an agreement with the Biomedical Advanced Research and Development Authority that will expand its planned manufacturing capacity in Fishers. The company says the deal, valued at up to $95 million, will produce vials to be used for current and future vaccine needs.... Read More
